Pharmaceuticals

Imperial College London is a hive of activity in drug discovery and development. Imperial hosts some of the world’s leading scientists as well as the affiliation with Imperial NHS trust, one of the largest academic health systems in Europe.

Based on these cutting edge capabilities, ICON has a proven record in assisting pharmaceutical companies and CROs to develop successful, ground-breaking medicines.

Our consultants are key opinion leader physicians and globally renowned researchers, who are committed to translating their expertise into practice in order to push the boundaries of drug development.

We have helped clients solve a range of problems:

 

SCIENTIFIC AND REGULATORY ADVICE AND PROTOCOL ASSISTANCE

Our academics have offered scientific, regulatory advice as well as assistance with clinical trial protocols in all therapeutic classes including rare diseases.`

 

PRE-CLINICAL DEVELOPMENT

Validated disease models in multiple therapeutic areas, high throughput screening, assays, pre-clinical species PK/PD, imaging, medicinal chemistry, structural synthesis pathways and lead optimisation strategy.

 

VACCINE DEVELOPMENT

Identification of antigens, reverse vaccinology, vaccine challenge tests for RSV, malaria and influenza.

 

MOLECULAR DIAGNOSTICS UNIT (MDU)

The CPA-accredited Molecular Diagnostic Unit (MDU) provides fast, accurate diagnostic tests for the management of infectious and genetic diseases using latest technology, including next generation sequencing and UPLC. Through ongoing research and development of new diagnostic methods it strives to remain ahead of the field in diagnostic testing and clinical monitoring.

The MDU supports the HIV and HTLV trials of the Clinical Trials Centre and patient management for The National Centre for Human Retrovirology and Imperial College Healthcare Trust.

Work to date has been centred on HIV, hepatitis viruses and sexually transmitted infections – but the clinical requirements of other clients can be catered for, click for more details

 

 

ACCESS TO FACILITIES

Genomics, biomarker discovery, high throughput mass spec, NMR, X-ray crystallography, advanced PET, advanced MRI, functional MRI and quantitative image analysis using AI.

Whether you need help with pre/clinical development or access to cutting edge validated assays and disease models, we can find the right people to help you solve a problem flexibly and responsively.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research.

Related Insights

Pandemics and privacy

Pandemics and privacy

Contact tracing apps will take and keep some data from users. This insight discusses ways of minimising privacy implications. read more

Do bots spread fake news?

Do bots spread fake news?

If bots aren’t responsible for spreading fake news, could automated systems form part of the solution, helping to identify false stories and check their spread? read more

Factories of the Future

Factories of the Future

Additive manufacturing is an automated production process enabling complex 3D designs to be transformed into physical objects. Read about the benefits and implications. read more

Related case studies

Imperial COVID-19 testing facilities

Imperial COVID-19 testing facilities

Imperial's facility, comprising the UKAS accredited Molecular Diagnostic Unit (MDU) and high-throughput robotic platform for RNA extraction, forms part of the Department of Health and Social Care's partnership with the London Testing Alliance, set-up by MedCity. read more

Cystic Fibrosis clinical advisory board

Cystic Fibrosis clinical advisory board

Our consultants shared their expertise in Cystic Fibrosis (CF), drug development and clinical trials to help Proteostasis Therapeutics assess the combination of compounds aimed at treatments to improve lung function. read more

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Latest news

Gravity-based energy storage could prove a cheaper option

Gravity-based energy storage could prove a cheaper option

Imperial researchers predict that gravity-fed energy storage systems may provide long-term savings - and analysis suggests that technology from Gravitricity is well suited to provide grid balancing and rapid frequency response services to grid operators. read more

FREE Congenital Anomalies webinar – ON DEMAND

FREE Congenital Anomalies webinar – ON DEMAND

Register to see the second in our series of four, educational webinars exploring Fetal Medicine. We will explore the common (and less common) structural, chromosomal and genetic congenital abnormalities. Delivered by Imperial’s Professor Christoph Lees, and supported by GE HealthCare. read more

FREE Fetal Brain webinar – LIVE

FREE Fetal Brain webinar – LIVE

Watch, LIVE, the last in our series of four, educational webinars exploring Fetal Medicine. In this, our panel will discuss imaging, investigation and management of different fetal cases - and it aims to be a truly virtual fetal neurology clinic. Delivered by Imperial’s Professor Christoph Lees, and supported by GE HealthCare. read more